The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
Background: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficacious adjuvant treatment opt...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
SAGE Publishing
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/b7c460474e584b6ca7677d4ff0d6ecf3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|